(Q50435046)

13 March 2018

title

Intratympanic gentamicin in Ménière's disease: our experience. (English)

1 reference

13 March 2018

0 references

L Pérez Delgado

1

1 reference

13 March 2018

J Fraile Rodrigo

series ordinal

2

1 reference

13 March 2018

P Astier Peña

series ordinal

3

1 reference

13 March 2018

publication date

15 February 2011

1 reference

13 March 2018

Journal of Laryngology and Otology

published in

1 reference

13 March 2018

volume

125

1 reference

13 March 2018

issue

4

1 reference

13 March 2018

page(s)

363-369

1 reference

13 March 2018

Intratympanic gentamicin for Menière's disease: a meta-analysis

cites work

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin for the treatment of Meniere's disease and other forms of peripheral vertigo

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Long-term results after interval therapy with intratympanic gentamicin for Menière's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Visualization of endolymphatic hydrops in patients with Meniere's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

The caloric reaction in Meniere's disease. An electronystagmographical study in 300 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin for intractable Meniere's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin for treatment of intractable Meniere's disease: a preliminary report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin in Meniere's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin therapy for Ménière's disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Efficacy of increased gentamicin concentration for intratympanic injection therapy in Ménière's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Treatment of Ménière's disease by intratympanic gentamicin application

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin for the treatment of unilateral Meniere's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Update on intratympanic gentamicin for Meniere's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Outcomes in the use of intra-tympanic gentamicin in the treatment of Ménière's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Long-term follow-up of transtympanic gentamicin for Ménière's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Intratympanic gentamicin in monolateral Meniere's disease: our experience.

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

Follow-Up Vestibular Examinalion in Meniere's Dlsease

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Menière

21 January 2018

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

7 January 2021

Long-term disability of class A patients with Ménière's disease after treatment with intratympanic gentamicin

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

7 January 2021

Electronystagmographic and audiologic findings in patients with Meniere's disease.

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

7 January 2021

Committee on Hearing and Equilibrium guidelines for the evaluation of results of treatment of conductive hearing loss. AmericanAcademy of Otolaryngology-Head and Neck Surgery Ffoundation, Inc

1 reference

https://api.crossref.org/works/10.1017%2FS0022215111000053

7 January 2021

10.1017/S0022215111000053

Identifiers

DOI

1 reference

13 March 2018

1 reference

13 March 2018